Skip to main content
. 2015 May 29;13:169. doi: 10.1186/s12967-015-0532-y

Figure 1.

Figure 1

Percentage of patients affected by metabolic syndrome (MS) in the two groups divided considering the median bisphenol-A (BPA) plasma value of 0.94 ng/ml. Four subjects out of 38 (11%) in the group with BPA plasma levels <0.94 ng/ml have MS, while 16 out of 38 (42%) were MS positive (MS+) in the group with BPA plasma levels >0.94 ng/ml.